Lip GYH - Search Results

1

Sodium-glucose cotransporter 2 inhibitors: An additional management option for patients with atrial fibrillation?

Proietti R, Lip GYH. Proietti R, et al. Among authors: lip gyh. Diabetes Obes Metab. 2022 Oct;24(10):1897-1900. doi: 10.1111/dom.14818. Epub 2022 Aug 5. Diabetes Obes Metab. 2022. PMID: 35837983 No abstract available.

2

Stroke prevention in atrial fibrillation patients.

Marinigh R, Lip GY, Lane DA. Marinigh R, et al. Expert Opin Pharmacother. 2010 Oct;11(14):2331-50. doi: 10.1517/14656566.2010.498819. Expert Opin Pharmacother. 2010. PMID: 20718589 Review.

3

Atrial fibrillation (acute onset).

Lip GY, Apostolakis S. Lip GY, et al. BMJ Clin Evid. 2011 Feb 15;2011:0210. BMJ Clin Evid. 2011. PMID: 21718559 Free PMC article. Review.

4

Looking through the PRISM: new insights for young patients with atrial fibrillation and stroke.

Banerjee A, Lip GY. Banerjee A, et al. Cerebrovasc Dis. 2011;32(4):383-4. doi: 10.1159/000331464. Epub 2011 Sep 15. Cerebrovasc Dis. 2011. PMID: 21921602 Free article. No abstract available.

5

Stroke and thromboembolism in atrial fibrillation.

Pisters R, Lane DA, Marin F, Camm AJ, Lip GY. Pisters R, et al. Circ J. 2012;76(10):2289-304. doi: 10.1253/circj.cj-12-1036. Epub 2012 Sep 19. Circ J. 2012. PMID: 23001018 Free article. Review.

6

Atrial fibrillation (acute onset).

Lip GY, Apostolakis S. Lip GY, et al. BMJ Clin Evid. 2014 Nov 27;2014:0210. BMJ Clin Evid. 2014. PMID: 25430048 Free PMC article. Review.

7

Atrial fibrillation (chronic).

Lane DA, Boos CJ, Lip GY. Lane DA, et al. BMJ Clin Evid. 2015 May 20;2015:0217. BMJ Clin Evid. 2015. PMID: 25994013 Free PMC article. Review.

8

Stroke in atrial fibrillation and improving the identification of 'high-risk' patients: the crossroads of immunity and thrombosis.

Shantsila E, Lip GY. Shantsila E, et al. J Thromb Haemost. 2015 Nov;13(11):1968-70. doi: 10.1111/jth.13121. Epub 2015 Sep 21. J Thromb Haemost. 2015. PMID: 26303061 Free article. No abstract available.

9

A comprehensive insight of novel antioxidant therapies for atrial fibrillation management.

Orenes-Piñero E, Valdés M, Lip GY, Marín F. Orenes-Piñero E, et al. Drug Metab Rev. 2015 Aug;47(3):388-400. doi: 10.3109/03602532.2015.1077858. Epub 2015 Aug 26. Drug Metab Rev. 2015. PMID: 27412960 Review.

10

Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial.

Essebag V, Proietti R, Birnie DH, Wang J, Douketis J, Coutu B, Parkash R, Lip GYH, Hohnloser SH, Moriarty A, Oldgren J, Connolly SJ, Ezekowitz M, Healey JS. Essebag V, et al. Among authors: lip gyh. Europace. 2017 Oct 1;19(10):1630-1636. doi: 10.1093/europace/euw409. Europace. 2017. PMID: 28339794 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,638 results

Search Page

Filters